MIGUEL ÁNGEL
CALLEJA HERNÁNDEZ
Chercheur dans le période 2016-2017
FERNANDO
MARTÍNEZ MARTÍNEZ
COLABORADOR EXTRAORDINARIO
Publications dans lesquelles il/elle collabore avec FERNANDO MARTÍNEZ MARTÍNEZ (23)
2024
-
Factors Contributing to Negative Outcomes Associated with Medications and Drug-Related Problems in Kidney Replacement Therapy—A Hospital-Based Prospective Observational Study
Journal of Clinical Medicine, Vol. 13, Núm. 4
2023
-
Medication Review with Follow-Up for End-Stage Renal Disease: Drug-Related Problems and Negative Outcomes Associated with Medication—A Systematic Review
Journal of Clinical Medicine, Vol. 12, Núm. 15
2021
-
Association between polymorphisms in the vitamin D receptor and susceptibility to multiple sclerosis
Pharmacogenetics and Genomics, Vol. 31, Núm. 2, pp. 40-47
-
Genetic polymorphisms on the effectiveness or safety of breast cancer treatment: Clinical relevance and future perspectives
Mutation Research - Reviews in Mutation Research, Vol. 788
-
Impact of a risk-sharing agreement in rheumatoid arthritis in Spain
Health Policy, Vol. 125, Núm. 3, pp. 335-340
2020
-
Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta
Mutation Research - Reviews in Mutation Research, Vol. 785
2019
-
Clinical pharmacy services: From cost-effectiveness analysis to a productivity indicators model
European Journal of Hospital Pharmacy
2015
-
Differences in cancer drug assessment between Spain and the United Kingdom
European Journal of Cancer, Vol. 51, Núm. 13, pp. 1843-1852
-
Pharmaceutical care in smoking cessation
Patient Preference and Adherence, Vol. 9, pp. 209-215
2014
-
Drug assessment by a Pharmacy and Therapeutics committee: From drug selection criteria to use in clinical practice
Therapeutics and Clinical Risk Management, Vol. 10, Núm. 1, pp. 527-535
-
Efectos de un programa de Atención Farmacéutica para pacientes con esclerosis múltiple sobre la adherencia al tratamiento inmunomodulador
Ars pharmaceutica, Vol. 55, Núm. 1, pp. 37-44
-
Results of the implementation of a pharmaceutical care programme for patients with multiple sclerosis
European Journal of Hospital Pharmacy, Vol. 21, Núm. 4, pp. 248-250
2013
-
Efectos de un programa de Atención Farmacéutica para pacientes con esclerosis múltiple sobre la adherencia al tratamiento inmunomodulador
Ars pharmaceutica, Vol. 54, Núm. 4, pp. 1-8
-
Effect of pharmacotherapy follow-up on treatment adherence and virologic and immune response in patients with human immunodeficiency virus
Latin American Journal of Pharmacy, Vol. 32, Núm. 3, pp. 441-447
-
Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma
International Journal of Clinical Pharmacy, Vol. 35, Núm. 6, pp. 1105-1112
-
Mejora del conocimiento sobre reacciones alérgicas cruzadas en dos grupos de medicamentos: b-lactámicos y AINEs
Farmacia Hospitalaria, Vol. 37, Núm. 6, pp. 499-509
2012
-
Adecuación de la profilaxis antimicrobiana perioperatoria en apendicitis
Atencion Farmaceutica, Vol. 14, Núm. 4, pp. 245-250
-
Effectiveness of the bevacizumab-irinotecan regimen in the treatment of recurrent glioblastoma multiforme: Comparison with other second-line treatments without this regimen
Oncology Letters, Vol. 4, Núm. 5, pp. 1114-1118
-
Estudio de adecuación a la ficha técnica de las prescripciones de trastuzumab en un hospital de tercer nivel
Farmacia Hospitalaria, Vol. 36, Núm. 3, pp. 135-140
-
La prescripción electrónica asistida: instrumento clave para la disminución de los problemas relacionados con los medicamentos en el hospital
Pharmaceutical care España, Vol. 14, Núm. 6, pp. 229-237